BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32772699)

  • 1.
    Hashiba Y; Umekita K; Minami H; Kawano A; Nagayasu E; Maruyama H; Hidaka T; Okayama A
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):16-21. PubMed ID: 32772699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
    Stewart DM; Ramanathan R; Mahanty S; Fedorko DP; Janik JE; Morris JC
    Acta Haematol; 2011; 126(2):63-7. PubMed ID: 21474923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report:
    De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
    Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
    Lambertucci JR; Leão FC; Barbosa AJ
    Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL; Schaefer JT; Dahiya A
    Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal obstruction due to
    Harshan M; Niyas VKM; Arjun R
    Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L; McCarthy AE; Faught C
    Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
    Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
    Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
    Choksi TT; Madison G; Dar T; Asif M; Fleming K; Clarke L; Danilewitz M; Hennawy R
    Am J Trop Med Hyg; 2016 Oct; 95(4):864-867. PubMed ID: 27527631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides stercoralis infestation in a patient with severe ulcerative colitis.
    Ghoshal UC; Alexender G; Ghoshal U; Tripathi S; Krishnani N
    Indian J Med Sci; 2006 Mar; 60(3):106-10. PubMed ID: 16569924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review.
    Ashiri A; Beiromvand M; Khanzadeh A
    Clin Rheumatol; 2019 Nov; 38(11):3093-3098. PubMed ID: 31123976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R; Joseph AJ; Chacko A
    Trop Gastroenterol; 2007; 28(4):176-7. PubMed ID: 18416349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Disseminated Paracoccidioidomycosis and Strongyloides Hyperinfection in a Patient with Human T-Lymphotropic Virus Type 1/2 Infection.
    Montenegro-Idrogo J; Chiappe-Gonzalez A; Vicente-Lozano E; Cornejo-Venegas G; Resurrección-Delgado C
    Am J Trop Med Hyg; 2024 May; 110(5):961-964. PubMed ID: 38531110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
    Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
    New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L; Fernandes L
    Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
    Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
    Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.